Ico Therapeutics, Inc.

Ordinary Shares International Reporting
Verified Company Profile 7/24/2017
Contact Info
  • 777 Hornby Street
  • 6th Floor
  • Vancouver, BC V6Z 1S4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
CIK 0001421642
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. 2005
Employees 5 a/o Jul 31, 2016
Company Officers/Contacts
Andrew Rae President, CEO
Michael Liggett CFO
Peter Hnik Chief Med. Officer
Company Directors
William Jarosz
Susan Koppy
Andrew Rae
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers LLP
250 Howe Street
Suite 700
Vancouver, BC, V6C 3S7
Securities Counsel
Blake, Cassels and Graydon LLP
595 Burrard St.
Suite 2600
Vancouver, BC, V7X 1L3
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Troutman Sanders LLP on 12/19/2013
ICOTF Security Details
Share Structure
Market Value1 $2,111,443 a/o Dec 08, 2017
Authorized Shares 0 a/o Jan 30, 2017
Outstanding Shares 84,457,713 a/o Apr 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 79,904,458 a/o Jan 30, 2017
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
ICO - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 13,370 (-28.16%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security